[ad_1]
Following the reopening of its offer on TiGenix, Takeda holds 96.08% of the shares of biotech. A takeover bid begins on Friday after which the TiGenix share will be removed from the Brussels Stock Exchange.
Following the reopening of its takeover bid (OPA ) which ended on July 3, Takeda obtained 95.76% of the shares of TiGenix
. Taking into account all securities owned by Takeda and its subsidiaries (including shares issued on July 2, 2018 as a result of Takeda's exercise of the warrants), the total rose to 96.08% .
After the first phase of its takeover, the Japanese group had already obtained 90.83% of the shares of Belgian biotech. The second acceptance period was open since June 20th.
As Takeda reached the threshold of 95%, he will proceed to a simplified withdrawal offer ("squeeze-out") worth expropriation of the last shareholders. It starts this Friday, July 6 to close on July 26. The results will be published five days later.
Securities not brought will therefore be considered as automatically transferred to the pharmaceutical group. As required by law, funds for the payment of undelivered securities will be deposited with the Caisse des dépôts et consignations.
At the end of the "squeeze out", the shares of TiGenix will be automatically canceled Euronext Brussels . A deletion of US certificates (ADS) will also be made.
Source link
